ACEKX
Price
$10.37
Change
-$0.21 (-1.98%)
Updated
Dec 18 closing price
AMEFX
Price
$24.22
Change
-$0.53 (-2.14%)
Updated
Dec 18 closing price
Ad is loading...

ACEKX vs AMEFX

Header iconACEKX vs AMEFX Comparison
Open Charts ACEKX vs AMEFXBanner chart's image
Invesco Equity and Income R5
Price$10.37
Change-$0.21 (-1.98%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer F2
Price$24.22
Change-$0.53 (-2.14%)
VolumeN/A
CapitalizationN/A
ACEKX vs AMEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACEKX vs. AMEFX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACEKX is a Hold and AMEFX is a Buy.

FUNDAMENTALS
Fundamentals
AMEFX has more cash in the bank: 126B vs. ACEKX (12.8B). AMEFX pays higher dividends than ACEKX: AMEFX (3.73) vs ACEKX (2.07). ACEKX was incepted earlier than AMEFX: ACEKX (15 years) vs AMEFX (16 years). ACEKX is a more actively managed with annual turnover of: 142.00 vs. AMEFX (40.00). AMEFX has a lower initial minimum investment than ACEKX: AMEFX (250) vs ACEKX (1000000). AMEFX annual gain was more profitable for investors over the last year : 10.88 vs. ACEKX (8.30). AMEFX return over 5 years is better than : 21.04 vs. ACEKX (13.11).
ACEKXAMEFXACEKX / AMEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years16 years-
Gain YTD7.3379.50877%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.8B126B10%
Annual Yield % from dividends2.073.7355%
Returns for 1 year8.3010.8876%
Returns for 3 years2.016.5731%
Returns for 5 years13.1121.0462%
Returns for 10 years20.9933.7662%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX56.303.32
+6.27%
MoonLake Immunotherapeutics
CVKD11.450.45
+4.09%
Cadrenal Therapeutics Inc
CMPX1.530.04
+2.68%
Compass Therapeutics
WAT373.72-0.29
-0.08%
Waters Corp
PSTX9.50-0.01
-0.11%
Poseida Therapeutics